Autor segons l'article: Sahebkar, Amirhossein; Sancho, Elena; Abello, David; Camps, Jordi; Joven, Jorge;
Departament: Medicina i Cirurgia
Autor/s de la URV: Camps Andreu, Jorge / Joven Maried, Jorge
Paraules clau: Α-ketoglutarate Non-alcoholic fatty liver disease Diagnosis Ck18-f Biomarker ?-ketoglutarate non-alcoholic fatty liver disease diagnosis ck18-f biomarker
Resum: © 2017 Wiley Periodicals, Inc. Currently, a liver biopsy remains the only reliable way to precisely diagnose non-alcoholic fatty liver disease (NAFLD) and establish the severity of liver injury, presence of fibrosis, and architecture remodeling. However, the cost and the intrinsic invasive procedure of a liver biopsy rules it out as a gold standard diagnostic test, and the imaging test are not the best choice due to the price, and currently is being refined. The lack of a biomarker of NAFLD pushes to develop this new line of research. The aim of the present systematic review is to clarify and update all the NAFLD biomarkers described in the literature until recently. We highlight α-ketoglutarate and CK18-F as currently the best potential biomarker of NAFLD. However, due to methodological differences, we propose the implementation of international, multicenter, multiethnic studies with larger population size, and biopsy proven NAFLD diagnosis to analyze and compare α-ketoglutarate and CK18-F as potential biomarkers of the silent evolution of NAFLD.
Àrees temàtiques: Química Physiology Odontología Nutrição Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Farmacia Enfermagem Educação física Clinical biochemistry Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciência de alimentos Ciência da computação Cell biology Biotecnología Biodiversidade
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 00219541
Adreça de correu electrònic de l'autor: jorge.camps@urv.cat jorge.joven@urv.cat
Identificador de l'autor: 0000-0002-3165-3640 0000-0003-2749-4541
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
Enllaç font original: https://onlinelibrary.wiley.com/doi/abs/10.1002/jcp.25779
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Journal Of Cellular Physiology. 233 (2): 849-855
Referència de l'ítem segons les normes APA: Sahebkar, Amirhossein; Sancho, Elena; Abello, David; Camps, Jordi; Joven, Jorge; (2018). Novel circulating biomarkers for non-alcoholic fatty liver disease: A systematic review.. Journal Of Cellular Physiology, 233(2), 849-855. DOI: 10.1002/jcp.25779
DOI de l'article: 10.1002/jcp.25779
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2018
Tipus de publicació: Journal Publications
Repositori URV